Short answer
GENESCO INC (GCO) filed an 8-K current report with the SEC on September 3, 2026 reporting Item 2.02 (Results of Operations and Financial Condition), Item EX-99.1 (Exhibit EX-99.1), Item EX-99.2 (Exhibit EX-99.2). Q2 fiscal 2026 results covered quarter ended August 1, 2026.
GENESCO INC 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Q2 fiscal 2026 results covered quarter ended August 1, 2026
- Press release and summary slide presentation furnished as Exhibits 99.1 and 99.2
- Non-GAAP measures include adjusted margins, operating income, pretax earnings, and continuing-operations EPS
- Investors should review Exhibit 99.1 for reported figures and reconciliations to GAAP metrics
Item EX-99.1 · Exhibit EX-99.1
- Q2 sales fell 3% to $530M, but adjusted operating loss narrowed to $8.3M from $14.3M
- GAAP EPS rose to $0.32 from ($1.79), aided by $22.5M tariff refunds; adjusted EPS remained negative at ($0.83)
- Journeys comparable sales increased 2% and Johnston & Murphy 4%, offset by Schuh comparable sales declining 9%
- Fiscal 2027 adjusted EPS outlook raised to the high end of $2.00–$2.40, while comparable sales guidance moved to flat
- Liquidity improved with cash of $57.1M and debt of $15.8M, versus $41.0M and $71.0M last year
Item EX-99.2 · Exhibit EX-99.2
- Q2 FY27 sales $529.9M, down 3%; e-commerce reached 22% of retail sales
- GAAP operating income $3.6M, an $18M improvement; tariff refunds contributed $22.5M, including interest
- Non-GAAP operating loss $8.3M, improving $6M; adjusted gross margin rose 140 basis points to 47.2%
- Journeys comps +2% and Johnston & Murphy comps +4%, while schuh outlook worsened to a low-double-digit decline
- FY27 adjusted EPS guidance raised to the high end of $2.00 to $2.40; inventory increased 8% to $540M
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other GENESCO INC 8-K filings
Get the next GCO 8-K as it lands
Follow GCO for push alerts, or ask the research agent what this filing means.